Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

1.4K
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
1.4K
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

1.6K
The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
1.6K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

868
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
868
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

1.3K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.3K
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

1.6K
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
1.6K
Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

764
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
764

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and functional factors influencing the outcome of laparoscopic Nissen fundoplication.

Revista espanola de enfermedades digestivas·2025
Same author

Iron therapy supplementation in inflammatory bowel disease patients with iron deficiency anemia: findings from a real-world analysis in Italy.

European journal of gastroenterology & hepatology·2024
Same author

Iron deficiency anemia impacts disease progression and healthcare resource consumption in patients with inflammatory bowel disease: a real-world evidence study.

Therapeutic advances in gastroenterology·2023
Same author

Indications and hemoglobin thresholds for red blood cell transfusion and iron replacement in adults with gastrointestinal bleeding: An algorithm proposed by gastroenterologists and patient blood management experts.

Frontiers in medicine·2022
Same author

Practical approach to irritable bowel syndrome-diarrhea beyond low-FODMAP diet.

Revista espanola de enfermedades digestivas·2022
Same author

Relevance and needs of irritable bowel syndrome (IBS): Comparison with inflammatory bowel disease (IBD). (Please, if you are not interested in IBS, read it.).

Gastroenterologia y hepatologia·2022

Related Experiment Video

Updated: Mar 11, 2026

Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes
06:01

Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes

Published on: July 26, 2024

1.1K

Functional and motor gastrointestinal disorders.

Fermín Mearin1, Enrique Rey2, Agustín Balboa1

  • 1Instituto de Trastornos Funcionales y Motores Digestivos, Servicio de Aparato Digestivo, Centro Médico Teknon, Barcelona, España.

Gastroenterologia Y Hepatologia
|November 28, 2016
PubMed
Summary

Digestive Disease Week highlighted new Rome IV criteria for functional gastrointestinal disorders, offering more restrictive diagnoses. Research also explored physiopathology, microbiota, and treatments for conditions like irritable bowel syndrome and gastroparesis.

Keywords:
AcalasiaAchalasiaCriterios diagnósticos de Roma IVDispepsia funcionalFunctional digestive disordersFunctional dispepsiaGastroparesiaGastroparesisIrritable bowel syndromeRome IV diagnostic criteriaSíndrome del intestino irritableTrastornos funcionales digestivos

More Related Videos

Gastrointestinal Motility Monitor GIMM
08:15

Gastrointestinal Motility Monitor GIMM

Published on: December 1, 2010

31.6K
Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice
07:41

Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice

Published on: February 3, 2016

14.8K

Related Experiment Videos

Last Updated: Mar 11, 2026

Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes
06:01

Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes

Published on: July 26, 2024

1.1K
Gastrointestinal Motility Monitor GIMM
08:15

Gastrointestinal Motility Monitor GIMM

Published on: December 1, 2010

31.6K
Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice
07:41

Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice

Published on: February 3, 2016

14.8K

Area of Science:

  • Gastroenterology
  • Functional Gastrointestinal Disorders
  • Digestive Disease Week 2016

Background:

  • Functional gastrointestinal disorders (FGIDs) represent a significant area of clinical and research interest.
  • The evolution of diagnostic criteria is crucial for accurate diagnosis and management of FGIDs.
  • Digestive Disease Week (DDW) serves as a key forum for presenting cutting-edge research in gastroenterology.

Purpose of the Study:

  • To summarize key findings and advancements presented at Digestive Disease Week concerning functional and motor gastrointestinal disorders.
  • To highlight the introduction and implications of the new Rome IV diagnostic criteria for FGIDs.
  • To review emerging data on the physiopathology and therapeutic strategies for various FGIDs.

Main Methods:

  • Review of selected presentations from Digestive Disease Week.
  • Explanation of the new Rome IV diagnostic criteria for common functional gastrointestinal disorders.
  • Discussion of studies comparing Rome IV and Rome III criteria, particularly for irritable bowel syndrome.
  • Synthesis of data on physiopathological alterations, therapeutic interventions, and dietary approaches.

Main Results:

  • The Rome IV criteria for functional gastrointestinal disorders were presented, noted as more restrictive than Rome III, especially for irritable bowel syndrome.
  • Studies indicated that aggregated physiopathological alterations correlate with increased symptom severity in FGIDs.
  • Efficacy and mechanisms of action were discussed for acotiamide (functional dyspepsia), domperidone (gastroparesis), and linaclotide (irritable bowel syndrome, constipation).
  • Favorable results of a low FODMAP diet for irritable bowel syndrome, including microbiota modulation, were reported.
  • Long-term efficacy data for achalasia treatments were also presented.

Conclusions:

  • The Rome IV criteria represent a significant update in the diagnosis of functional gastrointestinal disorders.
  • Understanding the interplay of physiopathology and symptom severity is key to managing FGIDs.
  • Emerging therapeutic options and dietary interventions, such as the low FODMAP diet, show promise for improving patient outcomes in FGIDs.